$PEN
Penumbra Inc

2018 Q1 Form 10-Q Financial Statement

#000132173218000065 Filed on May 08, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q4 2017 Q1
Revenue $102.7M $96.05M $73.21M
YoY Change 40.28% 31.39% 26.41%
Cost Of Revenue $36.14M $32.32M $25.50M
YoY Change 41.72% 21.86% 41.58%
Gross Profit $66.56M $63.73M $47.71M
YoY Change 39.51% 36.81% 19.56%
Gross Profit Margin 64.81% 66.35% 65.16%
Selling, General & Admin $54.50M $51.40M $42.72M
YoY Change 27.57% 23.56% 29.19%
% of Gross Profit 81.88% 80.66% 89.54%
Research & Development $8.013M $0.00 $7.034M
YoY Change 13.92% -100.0% 40.65%
% of Gross Profit 12.04% 0.0% 14.74%
Depreciation & Amortization $1.399M $1.200M $654.0K
YoY Change 113.91% 144.9% 30.8%
% of Gross Profit 2.1% 1.88% 1.37%
Operating Expenses $62.51M $59.87M $49.76M
YoY Change 25.64% 25.25% 30.69%
Operating Profit $4.045M $3.856M -$2.046M
YoY Change -297.7% -416.07% -211.5%
Interest Expense $749.0K $700.0K $644.0K
YoY Change 16.3% 16.67% 26.27%
% of Operating Profit 18.52% 18.15%
Other Income/Expense, Net -$290.0K $0.00 -$349.0K
YoY Change -16.91% -100.0% 55.8%
Pretax Income $4.504M $3.906M -$1.751M
YoY Change -357.22% -357.82% -182.56%
Income Tax -$1.938M -$5.904M $1.355M
% Of Pretax Income -43.03% -151.15%
Net Earnings $5.491M $9.083M -$3.106M
YoY Change -276.79% -479.09% -235.57%
Net Earnings / Revenue 5.35% 9.46% -4.24%
Basic Earnings Per Share $0.16 $0.27 -$0.10
Diluted Earnings Per Share $0.15 $0.25 -$0.10
COMMON SHARES
Basic Shares Outstanding 33.85M shares 33.61M shares 31.61M shares
Diluted Shares Outstanding 35.92M shares 35.83M shares 31.61M shares

Balance Sheet

Concept 2018 Q1 2017 Q4 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $215.4M $214.6M $231.6M
YoY Change -6.99% 66.61% 60.39%
Cash & Equivalents $50.64M $50.64M $109.4M
Short-Term Investments $162.6M $164.0M $122.3M
Other Short-Term Assets $12.80M $7.289M $3.209M
YoY Change 298.88% -23.26% 132.03%
Inventory $94.62M $94.90M $79.19M
Prepaid Expenses $4.112M $4.871M
Receivables $65.11M $58.01M $45.28M
Other Receivables $0.00 $0.00 $4.600M
Total Short-Term Assets $387.9M $382.2M $372.4M
YoY Change 4.18% 44.88% 46.8%
LONG-TERM ASSETS
Property, Plant & Equipment $32.00M $30.90M $22.91M
YoY Change 39.69% 43.96% 135.72%
Goodwill $8.414M $8.178M
YoY Change
Intangibles $28.24M $23.78M
YoY Change
Long-Term Investments $3.300M $0.00
YoY Change
Other Assets $968.0K $1.016M $612.0K
YoY Change 58.17% 108.62% 40.69%
Total Long-Term Assets $101.8M $94.43M $46.00M
YoY Change 121.22% 112.56% 114.27%
TOTAL ASSETS
Total Short-Term Assets $387.9M $382.2M $372.4M
Total Long-Term Assets $101.8M $94.43M $46.00M
Total Assets $489.7M $476.7M $418.4M
YoY Change 17.05% 54.63% 52.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.403M $6.757M $4.973M
YoY Change 48.86% 64.4% 23.64%
Accrued Expenses $42.85M $44.83M $33.59M
YoY Change 27.56% 41.45% 12.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $50.25M $51.58M $38.56M
YoY Change 30.31% 44.08% 13.49%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $17.19M $18.48M $828.0K
YoY Change 1975.85% 2142.48% -73.24%
Total Long-Term Liabilities $17.19M $18.48M $828.0K
YoY Change 1975.85% 2142.48% -73.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $50.25M $51.58M $38.56M
Total Long-Term Liabilities $17.19M $18.48M $828.0K
Total Liabilities $74.79M $76.26M $44.89M
YoY Change 66.59% 82.84% 21.09%
SHAREHOLDERS EQUITY
Retained Earnings $7.951M $1.996M -$5.767M
YoY Change -237.87% -175.01% -62.02%
Common Stock $34.00K $33.00K $33.00K
YoY Change 3.03% 6.45% 10.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $414.9M $400.4M $373.5M
YoY Change
Total Liabilities & Shareholders Equity $489.7M $476.7M $418.4M
YoY Change 17.05% 54.63% 52.07%

Cashflow Statement

Concept 2018 Q1 2017 Q4 2017 Q1
OPERATING ACTIVITIES
Net Income $5.491M $9.083M -$3.106M
YoY Change -276.79% -479.09% -235.57%
Depreciation, Depletion And Amortization $1.399M $1.200M $654.0K
YoY Change 113.91% 144.9% 30.8%
Cash From Operating Activities $10.71M -$910.0K $2.194M
YoY Change 388.06% -91.22% -205.79%
INVESTING ACTIVITIES
Capital Expenditures $2.823M -$5.720M $3.194M
YoY Change -11.62% -12.8% 186.46%
Acquisitions
YoY Change
Other Investing Activities $640.0K -$10.67M -$6.780M
YoY Change -109.44% -199.16% -349.26%
Cash From Investing Activities -$2.187M -$16.39M -$9.976M
YoY Change -78.08% -489.31% -721.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $106.6M
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$6.744M 2.450M $105.5M
YoY Change -106.39% -1.21% -7074.49%
NET CHANGE
Cash From Operating Activities $10.71M -910.0K $2.194M
Cash From Investing Activities -$2.187M -16.39M -$9.976M
Cash From Financing Activities -$6.744M 2.450M $105.5M
Net Change In Cash $2.168M -14.85M $97.85M
YoY Change -97.78% 304.63% -5034.49%
FREE CASH FLOW
Cash From Operating Activities $10.71M -$910.0K $2.194M
Capital Expenditures $2.823M -$5.720M $3.194M
Free Cash Flow $7.885M $4.810M -$1.000M
YoY Change -888.5% -226.58% -68.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-2209000 USD
CY2018Q1 pen Standardand Extended Product Warranty Accrual Increase Decreasefor Changesin Estimatefor Newand Preexisting Warranties
StandardandExtendedProductWarrantyAccrualIncreaseDecreaseforChangesinEstimateforNewandPreexistingWarranties
232000 USD
CY2017Q1 pen Stock Issuance Costs Incurred During Noncashor Partial Noncash Transaction
StockIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction
295000 USD
CY2018Q1 pen Stock Issuance Costs Incurred During Noncashor Partial Noncash Transaction
StockIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction
0 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6757000 USD
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7403000 USD
CY2018Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
65107000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
58007000 USD
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
65107000 USD
CY2017Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-299000 USD
CY2018Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-32000 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44825000 USD
CY2018Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42850000 USD
CY2017Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1115000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1569000 USD
CY2018Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
744000 USD
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2637000 USD
CY2017 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P13Y1M6D
CY2018Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P15Y8M12D
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
396810000 USD
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
404299000 USD
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4012000 USD
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4154000 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1290000 USD
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1454000 USD
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000 USD
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3500000 shares
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23900 shares
CY2017Q4 us-gaap Assets
Assets
476667000 USD
CY2018Q1 us-gaap Assets
Assets
489707000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
382234000 USD
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
6199000 USD
CY2018Q1 us-gaap Assets Current
AssetsCurrent
387938000 USD
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
23000 USD
CY2018Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
23000 USD
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
357000 USD
CY2018Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
744000 USD
CY2017Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
164288000 USD
CY2018Q1 dei Amendment Flag
AmendmentFlag
false
CY2018Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018Q1 dei Document Period End Date
DocumentPeriodEndDate
2018-03-31
CY2018Q1 dei Document Type
DocumentType
10-Q
CY2018Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001321732
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34262844 shares
CY2018Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2018Q1 dei Entity Registrant Name
EntityRegistrantName
Penumbra Inc
CY2017Q4 pen Accrued Liabilitiesfrom Acquisition Current
AccruedLiabilitiesfromAcquisitionCurrent
4752000 USD
CY2018Q1 pen Accrued Liabilitiesfrom Acquisition Current
AccruedLiabilitiesfromAcquisitionCurrent
1551000 USD
CY2017Q4 pen Allowancefor Sales Returns Current
AllowanceforSalesReturnsCurrent
3035000 USD
CY2018Q1 pen Allowancefor Sales Returns Current
AllowanceforSalesReturnsCurrent
3059000 USD
CY2017Q4 pen Clinical Trial Accruals Current
ClinicalTrialAccrualsCurrent
1514000 USD
CY2018Q1 pen Clinical Trial Accruals Current
ClinicalTrialAccrualsCurrent
1879000 USD
CY2017Q1 pen Equity Consideration For Buyout Agreement
EquityConsiderationForBuyoutAgreement
0 USD
CY2018Q1 pen Equity Consideration For Buyout Agreement
EquityConsiderationForBuyoutAgreement
5256000 USD
CY2018Q1 pen Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLoss
-351000 USD
CY2018Q1 pen Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Foreign Currency Translation
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossForeignCurrencyTranslation
-133000 USD
CY2017Q4 pen License Liability Noncurrent
LicenseLiabilityNoncurrent
12717000 USD
CY2018Q1 pen License Liability Noncurrent
LicenseLiabilityNoncurrent
11924000 USD
CY2018Q1 pen Numberof Business Activities
NumberofBusinessActivities
1 activity
CY2017 pen Standardand Extended Product Warranty Accrual Increase Decreasefor Changesin Estimatefor Newand Preexisting Warranties
StandardandExtendedProductWarrantyAccrualIncreaseDecreaseforChangesinEstimateforNewandPreexistingWarranties
471000 USD
CY2018Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
163357000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
101000 USD
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
155000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
357000 USD
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
744000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
144653000 USD
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
391000 USD
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
142625000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
256000 USD
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
589000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
132461000 USD
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.774
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.430
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
131235000 USD
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22001000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
12192000 USD
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
11390000 USD
CY2018Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25642000 USD
CY2017 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
200000 USD
CY2018Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
300000 USD
CY2017Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
163954000 USD
CY2018Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
162636000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
59682000 USD
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
27600000 USD
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M4D
CY2017Q1 us-gaap Gross Profit
GrossProfit
47709000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
21374000 USD
CY2018Q1 us-gaap Gross Profit
GrossProfit
66557000 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4504000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
104272000 USD
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
141262000 USD
CY2017Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2018Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
442000 USD
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
3017000 USD
CY2017Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
339000 USD
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
17392000 USD
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
14157000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
421000 USD
CY2018Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
427000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109383000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
683000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8982000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14500000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1751000 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4504000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50637000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8561000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52805000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13817000 USD
CY2017Q4 us-gaap Goodwill
Goodwill
8178000 USD
CY2018Q1 us-gaap Goodwill
Goodwill
8414000 USD
CY2018Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2018Q1 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
236000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13236000 USD
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111087000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50637000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52805000 USD
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
97851000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2168000 USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
33000 USD
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
34000 USD
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2344000 USD
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6559000 USD
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
25504000 USD
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
36144000 USD
CY2017Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1000 USD
CY2018Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
7345000 USD
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
26690000 USD
CY2018Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
28865000 USD
CY2018Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
28865000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3299000 USD
CY2018Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3371000 USD
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
654000 USD
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1399000 USD
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2017Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3106000 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
6442000 USD
CY2017Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2018Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-951000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1355000 USD
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1938000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
889000 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
622000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1880000 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6109000 USD
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4766000 USD
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2084000 USD
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6057000 USD
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-208000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2248000 USD
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2986000 USD
CY2017Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2018Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2070909 shares
CY2017Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
15217000 USD
CY2018Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
14424000 USD
CY2017Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
24199000 USD
CY2018Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
28924000 USD
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23778000 USD
CY2018Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28241000 USD
CY2017Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
644000 USD
CY2018Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
749000 USD
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
75299000 USD
CY2018Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
72216000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
94901000 USD
CY2018Q1 us-gaap Inventory Net
InventoryNet
94616000 USD
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13529000 USD
CY2018Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13537000 USD
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6073000 USD
CY2018Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8863000 USD
CY2017Q1 us-gaap Inventory Write Down
InventoryWriteDown
256000 USD
CY2018Q1 us-gaap Inventory Write Down
InventoryWriteDown
300000 USD
CY2017Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1400000 USD
CY2018Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1400000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
76259000 USD
CY2018Q1 us-gaap Liabilities
Liabilities
74786000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
476667000 USD
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
489707000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
51582000 USD
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
50253000 USD
CY2017Q4 us-gaap Long Term Investments
LongTermInvestments
3872000 USD
CY2018Q1 us-gaap Long Term Investments
LongTermInvestments
3286000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
105524000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6744000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9976000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2187000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2194000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10708000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-3106000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
5491000 USD
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3106000 USD
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5491000 USD
CY2018Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
49755000 USD
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
62512000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2046000 USD
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4045000 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11320000 USD
CY2018Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8774000 USD
CY2017Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
2462000 USD
CY2018Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
1893000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1016000 USD
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
968000 USD
CY2017Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
70000 USD
CY2018Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-318000 USD
CY2017Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
692000 USD
CY2018Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1386000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
762000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1068000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18478000 USD
CY2018Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17188000 USD
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-349000 USD
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-290000 USD
CY2017Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
114000 USD
CY2018Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
357000 USD
CY2017Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0 USD
CY2018Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
4323000 USD
CY2017Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2089000 USD
CY2018Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3530000 USD
CY2017Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
44777000 USD
CY2018Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
42552000 USD
CY2017Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
CY2018Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
352000 USD
CY2017Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2500000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3194000 USD
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2823000 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14735000 USD
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12774000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
106563000 USD
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2017Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
15020000 USD
CY2018Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
43540000 USD
CY2017Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2018Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-219000 USD
CY2017Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
22975000 USD
CY2018Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
CY2017Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1050000 USD
CY2018Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1328000 USD
CY2016Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1254000 USD
CY2017Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1088000 USD
CY2018Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1201000 USD
CY2017Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1088000 USD
CY2018Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1201000 USD
CY2017 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
637000 USD
CY2018Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
119000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30899000 USD
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31995000 USD
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7034000 USD
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8013000 USD
CY2017Q1 us-gaap Restricted Cash
RestrictedCash
1704000 USD
CY2018Q1 us-gaap Restricted Cash
RestrictedCash
0 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1996000 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7951000 USD
CY2017Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73213000 USD
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
102701000 USD
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
73213000 USD
CY2018Q1 us-gaap Sales Revenue Net
SalesRevenueNet
102701000 USD
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42721000 USD
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
54499000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4012000 USD
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4154000 USD
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
633 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2107104 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1989432 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.58
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.95
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.32
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
18.80
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
117039 shares
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
400408000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
414921000 USD
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31611841 shares
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35917051 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31611841 shares
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33846142 shares
CY2018Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:normal;font-weight:bold;text-decoration:none;">1. Organization and Description of Business</font><font style="font-family:Times New Roman;font-size:10pt;font-style:normal;font-weight:bold;text-decoration:none;"> </font></div><div style="line-height:120%;padding-top:12px;text-indent:24px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">Penumbra, Inc. (the &#8220;Company&#8221;) </font><font style="font-family:inherit;font-size:10pt;">is a global healthcare company focused on innovative therapies. The Company designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs.</font></div></div>
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:normal;font-weight:bold;text-decoration:none;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-indent:24px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and equity accounts; disclosure of contingent assets and liabilities at the date of the financial statements; and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including those related to marketable investments, provisions for doubtful accounts, sales return reserve, warranty reserve, valuation of inventories, useful lives of property and equipment, income taxes, and contingencies, among others. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other data. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001321732-18-000065-index-headers.html Edgar Link pending
0001321732-18-000065-index.html Edgar Link pending
0001321732-18-000065.txt Edgar Link pending
0001321732-18-000065-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pen-033118x10q.htm Edgar Link pending
pen-033118xexhibit311.htm Edgar Link pending
pen-033118xexhibit312.htm Edgar Link pending
pen-033118xexhibit321.htm Edgar Link pending
pen-20180331.xml Edgar Link completed
pen-20180331.xsd Edgar Link pending
pen-20180331_cal.xml Edgar Link unprocessable
pen-20180331_def.xml Edgar Link unprocessable
pen-20180331_lab.xml Edgar Link unprocessable
pen-20180331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending